$784.75 Million in Sales Expected for HB Fuller Co (FUL) This Quarter
Equities research analysts forecast that HB Fuller Co (NYSE:FUL) will post $784.75 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for HB Fuller’s earnings. The highest sales estimate is $795.56 million and the lowest is $780.22 million. HB Fuller posted sales of $562.87 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 39.4%. The company is scheduled to issue its next quarterly earnings results on Wednesday, September 26th.
On average, analysts expect that HB Fuller will report full-year sales of $3.12 billion for the current year, with estimates ranging from $3.09 billion to $3.16 billion. For the next year, analysts expect that the company will post sales of $3.25 billion per share, with estimates ranging from $3.18 billion to $3.29 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow HB Fuller.
HB Fuller (NYSE:FUL) last posted its earnings results on Wednesday, June 27th. The specialty chemicals company reported $0.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.03. The business had revenue of $789.39 million during the quarter, compared to the consensus estimate of $808.06 million. HB Fuller had a return on equity of 12.66% and a net margin of 4.00%.
HB Fuller stock opened at $58.31 on Friday. The company has a quick ratio of 1.46, a current ratio of 2.24 and a debt-to-equity ratio of 2.07. The company has a market cap of $2.95 billion, a P/E ratio of 22.09, a P/E/G ratio of 0.95 and a beta of 1.48. HB Fuller has a one year low of $46.62 and a one year high of $59.58.
In related news, VP Steven Kenny sold 2,200 shares of the firm’s stock in a transaction on Monday, July 30th. The stock was sold at an average price of $56.19, for a total transaction of $123,618.00. Following the completion of the sale, the vice president now directly owns 30,173 shares of the company’s stock, valued at approximately $1,695,420.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Traci L. Jensen sold 4,508 shares of the firm’s stock in a transaction on Thursday, August 9th. The shares were sold at an average price of $57.45, for a total value of $258,984.60. The disclosure for this sale can be found here. Insiders have sold a total of 12,208 shares of company stock valued at $680,263 over the last ninety days. Insiders own 3.46% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the stock. Piedmont Investment Advisors LLC increased its holdings in HB Fuller by 9.1% during the 2nd quarter. Piedmont Investment Advisors LLC now owns 11,783 shares of the specialty chemicals company’s stock valued at $633,000 after purchasing an additional 983 shares in the last quarter. D.A. Davidson & CO. increased its stake in shares of HB Fuller by 20.0% in the 2nd quarter. D.A. Davidson & CO. now owns 6,000 shares of the specialty chemicals company’s stock valued at $322,000 after buying an additional 1,000 shares during the period. Municipal Employees Retirement System of Michigan increased its stake in shares of HB Fuller by 4.7% in the 1st quarter. Municipal Employees Retirement System of Michigan now owns 23,610 shares of the specialty chemicals company’s stock valued at $1,175,000 after buying an additional 1,050 shares during the period. MetLife Investment Advisors LLC increased its stake in shares of HB Fuller by 5.5% in the 2nd quarter. MetLife Investment Advisors LLC now owns 23,194 shares of the specialty chemicals company’s stock valued at $1,245,000 after buying an additional 1,200 shares during the period. Finally, OppenheimerFunds Inc. increased its stake in shares of HB Fuller by 4.6% in the 2nd quarter. OppenheimerFunds Inc. now owns 28,752 shares of the specialty chemicals company’s stock valued at $1,543,000 after buying an additional 1,267 shares during the period. 97.65% of the stock is owned by hedge funds and other institutional investors.
About HB Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.
Featured Article: How Do Tariffs Affect Trade Balances?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.